Literature DB >> 16734820

Plasma ectonucleotidases prevent desensitization of purinergic receptors in stored platelets: importance for platelet activity during thrombus formation.

Sandra Cauwenberghs1, Marion A H Feijge, Geja Hageman, Marc Hoylaerts, Jan-Willem N Akkerman, Joyce Curvers, Johan W M Heemskerk.   

Abstract

BACKGROUND: Platelets (PLTs) contain purinergic receptors for ATP (P2X1) and ADP (P2Y1 and P2Y12) that rapidly desensitize upon stimulation with these nucleotides. In vivo, this is antagonized by ectonucleotidases on the surface of endothelial cells and white blood cells (WBCs). The receptor desensitization of ATP- and ADP-induced responses of PLTs stored in plasma without WBCs was investigated. STUDY DESIGN AND METHODS: ATP- and ADP-induced PLT shape change (shear-induced) aggregation and Ca2+ signaling were measured in the presence or absence of plasma. Degradation of nucleotides in plasma was quantified by high-performance liquid chromatography.
RESULTS: Washed PLTs became refractory for ATP and ADP in shape change, aggregation, and Ca2+ responses during a 90-minute incubation at 37 degrees C. The PLT responses mediated by P2X1, P2Y1, and P2Y12 receptors gradually reduced or disappeared. When plasma was present, however, the PLTs persistently showed high responses to ATP and ADP. Heat treatment of plasma abolished this effect. Also under conditions of flow and high shear, PLTs in plasma kept high P2X1 activity, mediating aggregate formation. In isolated plasma, not containing WBCs, nucleotides were degraded in the order of ADP/UDP>ATP/UTP. Degradation of ATP was partly inhibited by blocking the ecto-NTPDase CD39, whereas degradation of both ATP and ADP was inhibited by blocking ectopyrophosphatase/phosphodiesterase activity. Part of the nucleotide-degrading activities appeared to be membrane-bound.
CONCLUSION: Ectonucleotidases in plasma preserve the functionality of P2X1 and P2Y receptors. Upon PLT storage, these plasma activities are essential to ensure adequate (shear-dependent) formation of aggregates and thrombi.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16734820     DOI: 10.1111/j.1537-2995.2006.00837.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  11 in total

1.  Intravascular ADP and soluble nucleotidases contribute to acute prothrombotic state during vigorous exercise in humans.

Authors:  Gennady G Yegutkin; Sergei S Samburski; Stefan P Mortensen; Sirpa Jalkanen; José González-Alonso
Journal:  J Physiol       Date:  2007-01-04       Impact factor: 5.182

2.  Metabolism of circulating ADP in the bloodstream is mediated via integrated actions of soluble adenylate kinase-1 and NTPDase1/CD39 activities.

Authors:  Gennady G Yegutkin; Bé Wieringa; Simon C Robson; Sirpa Jalkanen
Journal:  FASEB J       Date:  2012-05-25       Impact factor: 5.191

Review 3.  Blood cells: an historical account of the roles of purinergic signalling.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2015-08-11       Impact factor: 3.765

4.  Ectonucleotidases in the kidney.

Authors:  David G Shirley; Renu M Vekaria; Jean Sévigny
Journal:  Purinergic Signal       Date:  2009-03-31       Impact factor: 3.765

5.  ATP antagonizes thrombin-induced signal transduction through 12(S)-HETE and cAMP.

Authors:  Jaione Burzaco; Manuel Conde; Luis A Parada; José L Zugaza; Jean-Paul Dehaye; Aida Marino
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

6.  The P2X1 receptor and platelet function.

Authors:  Martyn P Mahaut-Smith; Sarah Jones; Richard J Evans
Journal:  Purinergic Signal       Date:  2011-03-22       Impact factor: 3.765

7.  Extracellular Ca(2+) modulates ADP-evoked aggregation through altered agonist degradation: implications for conditions used to study P2Y receptor activation.

Authors:  Sarah Jones; Richard J Evans; Martyn P Mahaut-Smith
Journal:  Br J Haematol       Date:  2011-02-20       Impact factor: 6.998

8.  Some aspects of purinergic signaling in the ventricular system of porcine brain.

Authors:  Joanna Czarnecka; Katarzyna Roszek; Artur Jabłoński; Dariusz Jan Smoliński; Michał Komoszyński
Journal:  Acta Vet Scand       Date:  2011-10-13       Impact factor: 1.695

9.  Emphasis on the Role of PF4 in the Incidence, Pathophysiology and Treatment of Heparin Induced Thrombocytopenia.

Authors:  M Margaret Prechel; Jeanine M Walenga
Journal:  Thromb J       Date:  2013-04-05

10.  Role of Purinergic Receptor Expression and Function for Reduced Responsiveness to Adenosine Diphosphate in Washed Human Platelets.

Authors:  Juergen Koessler; Stephanie Hermann; Katja Weber; Angela Koessler; Sabine Kuhn; Markus Boeck; Anna Kobsar
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.